Health
Partnership to Explore Drug Delivery Approaches Labmate Online – Labmate Online
Reagents and therapeutics developer Aptamer Group has extended its existing collaboration with global biopharmaceutical company AstraZeneca to evaluate potential…
Reagents and therapeutics developer Aptamer Group has extended its existing collaboration with global biopharmaceutical company AstraZeneca to evaluate potential use of its Optimer-based strategies to target renal cells and the feasibility of developing next-generation drug delivery conjugates.
Based on oligonucleotide molecules optimers can bind specifically to a target molecule to act as an antibody alternative. Their ability to fold into distinct secondary or tertiary structures gives them high…
-
Noosa News15 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Noosa News16 hours agoForum responds to urgent homelessness issues in Nambour
-
Business14 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
General18 hours agoFirst home buyers score early access to deposit scheme